about
Schizophrenia and violence: systematic review and meta-analysisThe global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 studyFecal contamination of drinking-water in low- and middle-income countries: a systematic review and meta-analysisThe prevalence of mental disorders among the homeless in western countries: systematic review and meta-regression analysisThe global prevalence of schizophrenia.Reduced fertility in patients' families is consistent with the sexual selection model of schizophrenia and schizotypySchizophreniaChlorpromazine versus reserpine for schizophreniaChlorpromazine versus atypical antipsychotic drugs for schizophreniaChlorpromazine versus reserpine for schizophreniaPsychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illnessAsenapine versus placebo for schizophreniaAvatar therapy for schizophrenia or related disordersAsenapine versus placebo for schizophreniaPsychoeducation for siblings of people with severe mental illnessHorticultural therapy for schizophreniaIllness management and recovery programme for people with severe mental illnessTrifluoperazine versus placebo for schizophreniaTrifluoperazine versus placebo for schizophreniaChlorpromazine versus atypical antipsychotic drugs for schizophreniaQuetiapine versus placebo for schizophreniaPsychoeducation for siblings of people with severe mental illnessSpecialist interventions for homeless people with severe mental illnessFluphenazine (oral) versus atypical antipsychotics for schizophreniaClozapine dose for schizophreniaHorticultural therapy for schizophreniaReplication of association between working memory and Reelin, a potential modifier gene in schizophreniaDirect measure of the de novo mutation rate in autism and schizophrenia cohortsPsychiatric genocide: Nazi attempts to eradicate schizophreniaThe genetics of schizophreniaSecondary schizophreniaAuthors' Reply: Measurement Errors in Schizophrenia EpidemiologyFluphenazine (oral) versus atypical antipsychotics for schizophreniaForeign Accent Syndrome As a Psychogenic Disorder: A Review.Global economic burden of schizophrenia: a systematic reviewThe PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia.Brain Functional Effects of Psychopharmacological Treatments in Schizophrenia: A Network-based Functional Perspective Beyond Neurotransmitter SystemsAn evaluation of variation in published estimates of schizophrenia prevalence from 1990─2013: a systematic literature reviewGender differences in individuals at high-risk of psychosis: a comprehensive literature reviewCortical inhibition, excitation, and connectivity in schizophrenia: a review of insights from transcranial magnetic stimulation
P2860
Q21092358-CD7F93D1-862C-4DD6-9929-E2FACC69517BQ21132482-1956367D-F395-4790-90EA-0BF259D9B7C7Q21144592-83F78207-301B-4E3B-B118-0E031A2A30D2Q21144647-C900FE54-76B2-4386-BEC3-F5327720FE05Q21144735-3ED0C5FB-E1E7-4B9A-B244-8498FC13F843Q21562120-F63D2D93-E15F-43BF-9892-5A314EABC143Q22242092-D1EEF916-841D-4D35-A0B7-8DEA3A3E08B4Q24185855-19FE97D1-291A-460B-AD91-130C8C8C94B9Q24185922-80A1EC9A-0DD7-4D15-B67C-6263E213A1ABQ24186067-64E9AEA2-7B82-4EDD-9F85-F223A353BA75Q24186868-29A6CF97-7364-493C-9412-2C1B5883478DQ24187012-EEF2072E-1369-4D2C-ABF2-4D305B9957F6Q24187434-4FFB535C-F5FD-47CA-80C1-3EE07001F7EFQ24187667-382B95CB-3539-4E36-A568-E60AD106E284Q24188016-D656F116-0289-4A3D-B590-A4CEF6C87230Q24194604-AED79918-03CD-4899-96F5-BEFB141586BCQ24197641-948D35F0-9D3C-4682-B0B3-3F2072F4457EQ24197679-C7F91C46-7527-4281-AB52-17741E8C95A9Q24201149-F8F7110D-37CD-4B22-BD50-29D4121D104FQ24201691-DA48681B-4319-4533-9F39-451EAA7F10B1Q24202305-CB58C49F-A589-44AA-8D9A-7D414D049887Q24202476-FBBCF528-577B-4F32-B3B9-43B7DDC16B8AQ24202623-B84BDE19-9B37-4DF1-9DF0-D41A6DA53A67Q24202712-8C0DFBD9-C0B3-45BA-8166-BBD4C76F8496Q24203938-88603D41-7C9D-4E29-B858-2A83F87ECA7FQ24235731-1CC0D474-8438-4B26-A8F1-DF613B8389A8Q24606481-724779FF-75B3-4699-9DE8-BE646057F28EQ24618002-E045C3F1-CC2A-4689-A09C-B499369E7620Q24652182-D1859764-3540-4329-A180-512653E71FF9Q24815806-2C11D492-C88D-4126-B2D1-1EEADCF6ED3CQ24816352-8274484F-3AEF-48FA-99C3-F5CE11796AFFQ24816394-0DC2504A-38A5-497A-965F-4E167EE86766Q26471188-43451574-92DE-4B60-9EAB-5D584BDD0F58Q26747541-A0BD4DA3-E8EE-4493-883D-2AD3A2D04A4FQ26764888-9D36C83A-35CB-4996-9CAC-B23E44BF150EQ26766054-6AE69CDC-3478-4F13-AE32-81F84645C8AFQ26786247-A4D8EBCA-8A9D-4A56-ABE9-CB84CA28C0DBQ26799270-807EFE65-4C41-46E1-A6FB-BF27DD591A07Q26826971-7BACC2C3-0B6C-4FA2-8DDC-75F54F4C4285Q26853430-B68D4D86-17D2-4B6E-B97E-FA27EF2FBC54
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A systematic review of the prevalence of schizophrenia
@nl
A systematic review of the prevalence of schizophrenia.
@ast
A systematic review of the prevalence of schizophrenia.
@en
A systematic review of the prevalence of schizophrenia.
@en-gb
type
label
A systematic review of the prevalence of schizophrenia
@nl
A systematic review of the prevalence of schizophrenia.
@ast
A systematic review of the prevalence of schizophrenia.
@en
A systematic review of the prevalence of schizophrenia.
@en-gb
altLabel
A Systematic Review of the Prevalence of Schizophrenia
@en
prefLabel
A systematic review of the prevalence of schizophrenia
@nl
A systematic review of the prevalence of schizophrenia.
@ast
A systematic review of the prevalence of schizophrenia.
@en
A systematic review of the prevalence of schizophrenia.
@en-gb
P2093
P2860
P31
P921
P3181
P1433
P1476
A systematic review of the prevalence of schizophrenia.
@en
P2093
David Chant
Joy Welham
Sukanta Saha
P2860
P3181
P356
10.1371/JOURNAL.PMED.0020141
P407
P577
2005-05-01T00:00:00Z
2005-05-31T00:00:00Z